Jeffrey Pollak named the inaugural Robert I. White Jr., M.D. Professor
Jeffrey S. Pollak, appointed as the inaugural Robert I. White Jr., M.D. Professor of Interventional Radiology, has interest in embolotheraphy, including for acquired and congenital vascular abnormalities and malformations, fibroids, and malignancies, as well as other minimally invasive treatments for tumors, including local ablation.Source: Yale News
Robert White, MD, Receives 2010 Career Achievement Award
Dr. White is a professor of diagnostic radiology and the director of the Vascular Malformation Center at Yale University. After training in medicine, cardiology and diagnostic radiology at Johns Hopkins Hospital, he served as the director of its Cardiovascular Diagnostic Laboratory for 17 years before taking on the chairmanship of diagnostic radiology at Yale in 1988.
Portnoy: Working With Perpetrators of Intimate Partner Violence
In addition to its toll on physical health and economic well-being, the pandemic has exposed the often overlooked crisis of intimate partner violence, writes Galina Portnoy, PhD, Associate Research Scientist in Psychiatry at Yale School of Medicine.Source: Closler
Portnoy, Martino, Brandt to Develop New Intimate Partner Violence Center at VA Connecticut
Yale Psychiatry faculty Galina Portnoy, PhD, Associate Research Scientist, Steve Martino, PhD, Professor of Psychiatry, and Cynthia Brandt, MD, MPH, Professor of Emergency Medicine, will lead the development of a new Intimate Partner Violence Center for Innovation and Research (IPV-CIR) at the VA Connecticut Healthcare System (VACHS).
Rhee: Trends in Co-Prescribing of Opioids and Opioid Potentiators Among U.S. Adults, 2007–2018
Lead author Greg Rhee, PhD, Assistant Professor Adjunct in the Department of Psychiatry, explores trends in co-prescribing opioids and opioid potentiators among U.S. adults in a recent article published in the American Journal of Preventive Medicine.Source: American Journal of Preventive Medicine
Treatment with Genetically Altered Viruses Targets and Destroys Ovarian Cancer in Mice
Researchers have successfully eliminated chemotherapy-resistant ovarian cancer cells in mice using a single injection of two viruses genetically combined and altered to be safe, leading to long-term survival and demonstrating a potential breakthrough treatment for women.
Crusto Receives Award for Distinguished Contribution to Diversity in Psychology
Cindy Crusto, PhD, Associate Professor and Deputy Chair for Diversity, Equity and Inclusion in the Department of Psychiatry at Yale School of Medicine, is the 2020 recipient of the Connecticut Psychological Association (CPA) Award for Distinguished Contribution to Diversity in Psychology.
Clearing the Haze: What Do We Still Need to Learn About Electronic Nicotine Delivery Systems?
Important questions remain regarding the relative benefits versus risks of electronic nicotine delivery systems (ENDS). In light of these challenges, the authors propose key ENDS research priorities to address these gaps.Source: Cancer Prevention Research
Addiction Psychiatry Division Will Participate in Consortium to Develop New Treatment Tools for Addiction
Yale School of Medicine’s Division of Addiction Psychiatry will participate in a consortium funded by a multimillion-dollar federal grant that will attempt to develop new treatment tools for addiction.
Yarnell-Mac Grory Elected to Serve on Duke’s Fuqua School of Business Judicial Board
Stephanie Yarnell-Mac Grory, MD, PhD, faculty within Psychiatry at Yale School of Medicine and a graduate of the Yale Psychiatry Residency Program, Law and Psychiatry Fellowship Program, Addiction Psychiatry Fellowship Program, and former chief resident, has been elected to serve as a student representative on Duke University’s Fuqua School of Business’ Judicial Board.
DeSouza, Parker: COVID-19 Church Closures Could Strain Mental Health of African Americans
A new paper by Yale Psychiatry faculty explores how the closure of predominately African American church buildings — or the Black Church — during the COVID-19 pandemic could strain the mental health of African Americans, specifically as they cope with American racism without physical access to their places of worship.
Using the New Indication for Esketamine to Treat Patients with Major Depressive Disorder
Gerard Sanacora, MD, PhD, George D. and Esther S. Gross Professor of Psychiatry, spoke on a Psychiatric Times podcast about the new indication for esketamine, SPRAVATO®, and how it might be used to treat patients with Major Depressive Disorder with acute risk of suicide ideation.Source: Psychiatric Times